Related Experiment Video
Updated: Nov 7, 2025

Rating L-DOPA-Induced Dyskinesias in the Unilaterally 6-OHDA-Lesioned Rat Model of Parkinson's Disease
Published on: October 4, 2021
Genetic updates on paroxysmal dyskinesias.
James Y Liao1, Philippe A Salles1,2, Umar A Shuaib1
1Center for Neurological Restoration, Neurological Institute, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH, 44195, USA.
Paroxysmal dyskinesias are genetic disorders causing episodic movements. Advances in genetic sequencing reveal numerous gene variants, aiding diagnosis and treatment collaboration among scientists and clinicians.
Area of Science:
- Genetics
- Neurology
- Movement Disorders
Background:
- Paroxysmal dyskinesias are a heterogeneous group of genetic disorders characterized by episodic involuntary movements.
- Recent genetic sequencing advances have identified numerous associated gene variants, highlighting genotype-phenotype overlap, incomplete penetrance, and variability.
- Paroxysmal dyskinesia can be the initial presenting symptom of various genetic conditions.
Purpose of the Study:
- To review the 34 genes implicated in paroxysmal dyskinesias to date.
- To propose a diagnostic workflow utilizing whole-exome or whole-genome sequencing.
- To foster a unified understanding for effective collaboration in diagnosis and treatment.
Main Methods:
- Comprehensive literature review of genetic disorders causing paroxysmal dyskinesias.
- Analysis of current genetic sequencing technologies and their application.
- Development of a proposed diagnostic algorithm.
Main Results:
- Identification and discussion of 34 genes associated with paroxysmal dyskinesias.
- Emphasis on the complexity of genetic underpinnings, including variable penetrance and phenotypic expression.
- Highlighting the diagnostic utility of advanced genetic sequencing.
Conclusions:
- Genetic sequencing is crucial for diagnosing paroxysmal dyskinesias.
- A standardized diagnostic approach is needed for improved patient care.
- Enhanced collaboration between researchers and clinicians is essential for advancing the field.
More Related Videos
10:41Implantation of Osmotic Pumps and Induction of Stress to Establish a Symptomatic, Pharmacological Mouse Model for DYT/PARK-ATP1A3 Dystonia
Published on: September 12, 2020
05:51Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease
Published on: October 14, 2021
Related Concept Videos
Parkinson's Disease: Overview
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...